Dr. Harold Modrow, Ph.D.
Research and Development, Government and Regulatory Affairs
Dr. Modrow is the former Division Manager and Director of Life Sciences for Leidos Inc. in Frederick MD. In these roles, Dr. Modrow oversaw a staff of approximately 150 Leidos scientific and support staff, supporting numerous contracts with an annual revenue stream in excess of $50M. While at Leidos, Dr. Modrow has served in numerous positions including the Chief of Staff and Scientific Advisor to the Director of the DHS National Biothreat Analysis and Characterization Center and Program Manager for many government contracts in the biomedical arena.
Dr. Modrow retired from the Army in 2005 after serving 22 years of active duty. During that time, he held a number of positions, primarily in the areas of medical chemical defense and medical product development. He is the former Director of Plans, Programs, Analysis and Execution for USAMRMC, Deputy Commander of the US Army Medical Materiel Development Activity and the first DoD Board selected Program Manager for the Medical Chemical Defense Product Management Office. While in that role, he was responsible for the FDA approval of Pyridostigmine for the treatment of nerve agent exposure and the initial development of the JBAIDS PCR Diagnostic device for field use. In 2003, he deployed to Iraq as a part of a US Special Operations Command team to oversee the deployment and use of a unique hemostatic dressing for use by Special Operations teams on the battlefield. This bandage was developed under his leadership at USAMMDA and approved for emergency battlefield use by the FDA at the start of Operation Iraqi Freedom. He holds a level III certification in Program Management from DAU, is a member of the Order of Military Medical Merit and was awarded the Surgeon General’s “A” Professional Designator.
After receiving his Bachelor of Arts degree in Biology and Psychology from Hope College, Dr. Modrow received a Master’s degree in Biopsychology from Binghamton University and a Ph.D. in Psychology from Southern Illinois University with post-doctoral work in behavioral pharmacology at the University of Oklahoma School of Medicine. He is a graduate of the Army Command and General Staff College, DAU Program Management Course and Airborne School. He belongs to a number of scientific societies. He has published over 60 articles in scientific and military publications. We are honored to have him.